Technology
FDA Panel Backs Moderna’s COVID-19 Vaccine for Use In the US
An FDA advisory panel on Thursday backed Moderna’s COVID-19 vaccine, which is said to be 94% effective. It could be administered as soon as next week.
An FDA advisory panel on Thursday backed Moderna’s COVID-19 vaccine, which is said to be 94% effective. It could be administered as soon as next week.